ECEli M. Cahan

Eli M. Cahan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eli M. Cahan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Does healthcare system device volume correlate with price paid for spinal implants: a cross-sectional analysis of a national purchasing database

    by Eli Cahan, Kelly McFarlane, Nicole Segovia, Amanda Chawla, James Wall, Kevin Shea

    Objectives Amid continuously rising US healthcare costs, particularly for inpatient and surgical services, strategies to more effectively manage supply chain expenses are urgently necessary. Across industries, the ‘economy of scale’ principle indicates that larger purchasing volumes should correspond to lower prices due to ‘bulk discounts’. Even as such advantages of scale have driven health system mergers in the USA, it is not clear whether they are being achieved, including for specialised products like surgical implants which may be more vulnerable to cost inefficiency. The objective of this observational cross-sectional study was to investigate whether purchasing volumes for spinal implants was correlated with price paid. Setting USA. Participants Market data based on pricing levels for spine implants were reviewed from industry implant price databases. Filters were applied to narrow the sample to include comparable institutions based on procedural volume, patient characteristics and geographical considerations. Information on the attributes of 619 health systems representing 12 471 provider locations was derived from national databases and analytics platforms. Primary outcome measure Institution-specific price index paid for spinal implants, normalised to the national average price point achieved. Results A Spearman’s correlation test indicated a weak relationship between purchasing volume and price index paid (ρ=−0.35, pConclusions National supply chain data revealed that there was no significant relationship between purchasing volume and price paid by health systems for spinal implants. These findings suggest that factors other than purchasing or patient volume are responsible for setting prices paid by health systems to surgical vendors and/or larger healthcare systems are not negotiating in a way to consistently achieve optimal pricing.


  • The Impact of Telehealth Adoption During COVID-19 Pandemic on Patterns of Pediatric Subspecialty Care Utilization

    by Eli M. Cahan, Jay Maturi, Paige Bailey, Susan Fernandes, Ananta Addala, Sara Kibrom, Jill R. Krissberg, Stephanie M. Smith, Sejal Shah, Ewen Wang, et al.


  • Influence of team composition on turnover and efficiency of total hip and knee arthroplasty

    by Eli M. Cahan, Henry C. Cousins, Joshua T. Steere, Nicole A. Segovia, Matthew D. Miller, Derek F. Amanatullah

    Aims: Surgical costs are a major component of healthcare expenditures in the USA. Intraoperative communication is a key factor contributing to patient outcomes. However, the effectiveness of communication is only partially determined by the surgeon, and understanding how non-surgeon personnel affect intraoperative communication is critical for the development of safe and cost-effective staffing guidelines. Operative efficiency is also dependent on high-functioning teams and can offer a proxy for effective communication in highly standardized procedures like primary total hip and knee arthroplasty. We aimed to evaluate how the composition and dynamics of surgical teams impact operative efficiency during arthroplasty. Methods: We performed a retrospective review of staff characteristics and operating times for 112 surgeries (70 primary total hip arthroplasties (THAs) and 42 primary total knee arthroplasties (TKAs)) conducted by a single surgeon over a one-year period. Each surgery was evaluated in terms of operative duration, presence of surgeon-preferred staff, and turnover of trainees, nurses, and other non-surgical personnel, controlling cases for body mass index, presence of osteoarthritis, and American Society of Anesthesiologists (ASA) score. Results: Turnover among specific types of operating room staff, including the anaesthesiologist (p = 0.011), circulating nurse (p = 0.027), and scrub nurse (p = 0.006), was significantly associated with increased operative duration. Furthermore, the presence of medical students and nursing students were associated with improved intraoperative efficiency in TKA (p = 0.048) and THA (p = 0.015), respectively. The presence of surgical fellows (p > 0.05), vendor representatives (p > 0.05), and physician assistants (p > 0.05) had no effect on intraoperative efficiency. Finally, the presence of the surgeon’s 'preferred' staff did not significantly shorten operative duration, except in the case of residents (p = 0.043). Conclusion: Our findings suggest that active management of surgical team turnover and composition may provide a means of improving intraoperative efficiency during THA and TKA. Cite this article: Bone Joint J 2021;103-B(2):347–352.


  • Rwanda’s secret weapon against covid-19: trust

    by Eli M Cahan

    Surrounded by neighbours with heavy caseloads and lacking the resources of richer countries, Rwanda has nonetheless tamped down the virus so far. Agnes Binagwaho, an architect of the country’s health system, tells Eli M Cahan how


  • Open Access

    Data Heterogeneity: The Enzyme to Catalyze Translational Bioinformatics?

    by Eli M Cahan, Purvesh Khatri

    Up to 95% of novel interventions demonstrating significant effects at the bench fail to translate to the bedside. In recent years, the windfalls of “big data” have afforded investigators more substrate for research than ever before. However, issues with translation have persisted: although countless biomarkers for diagnostic and therapeutic targeting have been proposed, few of these generalize effectively. We assert that inadequate heterogeneity in datasets used for discovery and validation causes their nonrepresentativeness of the diversity observed in real-world patient populations. This nonrepresentativeness is contrasted with advantages rendered by the solicitation and utilization of data heterogeneity for multisystemic disease modeling. Accordingly, we propose the potential benefits of models premised on heterogeneity to promote the Institute for Healthcare Improvement’s Triple Aim. In an era of personalized medicine, these models can confer higher quality clinical care for individuals, increased access to effective care across all populations, and lower costs for the health care system.


  • Achieving a Quintuple Aim for Telehealth in Pediatrics

    by Eli M. Cahan, Vandna Mittal, Nirav R. Shah, Sonoo Thadaney-Israni


  • COVID-19 cancels charity galas and walks. Science is paying the price

    by Eli Cahan

    Nonprofits that fund research are delaying, trimming, or canceling grants to scientists


  • Supply Chain Optimization and Waste Reduction

    by Eli M. Cahan, Amanda Chawla, Kevin G. Shea

    To the Editor Drs Thiel and Horwitz described the importance of supply chain optimization to improve value in health care, focusing on medical waste minimizatio


  • Open Access

    Data Heterogeneity: The Enzyme to Catalyze Translational Bioinformatics? (Preprint)

    by Eli M Cahan, Purvesh Khatri

    UNSTRUCTURED Up to 95% of novel interventions demonstrating significant effects at the bench fail to translate to the bedside. In recent years, the windfalls of “big data” have afforded investigators more substrate for research than ever before. However, issues with translation have persisted: although countless biomarkers for diagnostic and therapeutic targeting have been proposed, few of these generalize effectively. We assert that inadequate heterogeneity in datasets used for discovery and validation causes their nonrepresentativeness of the diversity observed in real-world patient populations. This nonrepresentativeness is contrasted with advantages rendered by the solicitation and utilization of data heterogeneity for multisystemic disease modeling. Accordingly, we propose the potential benefits of models premised on heterogeneity to promote the Institute for Healthcare Improvement’s Triple Aim. In an era of personalized medicine, these models can confer higher quality clinical care for individuals, increased access to effective care across all populations, and lower costs for the health care system.